REQUEST A DEMO
Total
USD $0.00
Search more companies

Dorottyapharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: DOROTTYAPHARMA Gyogyszerkereskedelmi es Szolgaltato Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dorottyapharma Bt. is based in Hungary. The head office is in Jobbagyi. It operates in the Pharmacies and Drug Stores industry. Dorottyapharma Bt. was incorporated on May 19, 1998. There are currently 4 (2024) people employed by Dorottyapharma Bt.. In 2023, the company reported a net sales revenue increase of 14.7%. Its’ total assets recorded a negative growth of 2.08%. Dorottyapharma Bt.’s net profit margin increased by 1.86% in 2023.

Headquarters
Apponyi ut 89.
Jobbagyi; Nograd; Postal Code: 3063

Contact Details: Purchase the Dorottyapharma Bt. report to view the information.

Website: http://www.dorottyagyogyszertar.hu

Basic Information
Total Employees:
Purchase the Dorottyapharma Bt. report to view the information.
Outstanding Shares:
Purchase the Dorottyapharma Bt. report to view the information.
Registered Capital:
Purchase the Dorottyapharma Bt. report to view the information.
Financial Auditors:
Purchase the Dorottyapharma Bt. report to view the information.
Incorporation Date:
May 19, 1998
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Dorottyapharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
14.7%
Total operating revenue
14.32%
Operating profit (EBIT)
172.71%
EBITDA
80.21%
Net Profit (Loss) for the Period
420.57%
Total assets
-2.08%
Total equity
39.51%
Operating Profit Margin (ROS)
1.95%
Net Profit Margin
1.86%
Return on Equity (ROE)
20.73%
Quick Ratio
-0.02%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?